Barbara Bernardo

机构：Pfizer (United States) · ORCID：0009-0000-6272-4272

发表论文 17 篇 · 总被引 1328 次 · h-index 11

代表论文

FGF21 Regulates Sweet and Alcohol Preference (2015 · Cell Metabolism · 被引 341)
An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD) (2024 · Nature Metabolism · 被引 245)
Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis (2023 · The Lancet. Gastroenterology & hepatology · 被引 199)
Myostatin Inhibition Enhances the Effects of Exercise on Performance and Metabolic Outcomes in Aged Mice (2009 · The Journals of Gerontology Series A · 被引 175)
Glycolytic fast‐twitch muscle fiber restoration counters adverse age‐related changes in body composition and metabolism (2013 · Aging Cell · 被引 91)
Pharmacokinetics (PK), Pharmacodynamics (PD) and Integrated PK/PD Modeling of a Novel Long Acting FGF21 Clinical Candidate PF-05231023 in Diet-Induced Obese and Leptin-Deficient Obese Mice (2015 · PLoS ONE · 被引 68)